NIH-funded research NIH-funded research

Using genes to find new risk factors and treatments for carotid artery disease

Official title: Leveraging the Genetics of carotid stenosis for identifying novel risk factors and therapeutic opportunities

Funded at Philadelphia VA Medical Center · NIH-11400857 · Data updated 2026-11-12

Researchers are using big genetic data to uncover why carotid artery disease occurs and to find new ways to prevent and treat it for people at risk.

More Risk Factors research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionPhiladelphia VA Medical Center
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJuly 1, 2023
Project endJune 30, 2027
Funding year2026
NIH project number5I01BX006159-04
Project IDNIH-11400857 on NIH RePORTER

Who could benefit from this research

Could help

Adults with carotid stenosis or at risk for cerebrovascular ASCVD who contribute data or biospecimens to large-scale genetic studies through VA programs may be eligible.

Less likely to help

Individuals without access to VA programs or without carotid disease may not directly benefit.

What this research studies

This project aims to understand how genetic differences influence carotid artery disease and identify potential targets for prevention and therapy. It leverages large datasets from the VA Million Veteran Program and uses natural language processing to analyze medical records and genetic information. The work focuses on understanding disease-specific biology in the cerebrovascular system and how it differs from other ASCVD conditions, with the goal of guiding personalized prevention and treatment strategies. By linking genes, lifestyle factors, and military exposures, the study seeks to reveal new biomarkers and possible therapeutic opportunities for patients affected by carotid stenosis and related cerebrovascular disease.

Why it matters

Potential benefit: If successful, the work could lead to personalized prevention strategies and new therapeutic targets for patients with carotid artery disease.

How similar studies have gone: Prior genetic studies have identified new biology and therapeutic targets in CHD and PAD, but cerebrovascular genetic work has lagged; this project builds on that foundation with a novel focus on carotid disease.

Where this research is happening

  • Philadelphia VA Medical Center
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Damrauer, Scott Michael — Philadelphia VA Medical Center
  • Study coordinator: Damrauer, Scott Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.